Beck, Alexander <br/><br/>
Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.  [electronic resource] 

 -  Cancer biology & therapy  11 2016 
 - 1168-1176 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.1080/15384047.2016.1235664  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Growth Processes--drug effects<br/>Child, Preschool<br/>Cisplatin--administration & dosage<br/>Drug Synergism<br/>Female<br/>Hep G2 Cells<br/>Hepatoblastoma--drug therapy<br/>Histone Deacetylase Inhibitors--administration & dosage<br/>Histone Deacetylases--biosynthesis<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Risk Factors<br/>Transcriptome